Miller Children's Hospital
Welcome,         Profile    Billing    Logout  
 9 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Termuhlen, Amanda
NCT01595048 / 2010-019224-31: Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia

Active, not recruiting
2/3
640
US, Canada, RoW
Rituximab, MOAB IDEC-C2B8, Prednisone, Etoposide, Lastet, Doxorubicin Hydrochloride, Cytarabine, CHX-3311, U-19920, Vincristine Sulfate, Kyocristine, Oncovin, VCR, Vincasar, Cyclophosphamide, Methotrexate, Methylprednisolone, MePRDL, Leucovorin Calcium, CF, Therapeutic Hydrocortisone, Aeroseb-HC, Cetacort, HC, Laboratory Biomarker Analysis
Children's Oncology Group, National Cancer Institute (NCI)
Childhood B Acute Lymphoblastic Leukemia, Childhood Burkitt Leukemia, Childhood Diffuse Large Cell Lymphoma, Mediastinal (Thymic) Large B-Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma
12/20
12/20
NCT01000753: Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

Completed
N/A
174
Canada, US, RoW
Cytology Specimen Collection Procedure, Cytologic Sampling
Children's Oncology Group, National Cancer Institute (NCI)
Adult Immunoblastic Lymphoma, Central Nervous System Non-Hodgkin Lymphoma, Childhood Immunoblastic Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3 Follicular Lymphoma, Lymphoproliferative Disorder, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Non-Hodgkin Lymphoma, Primary Cutaneous B-Cell Non-Hodgkin Lymphoma, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Small Lymphocytic Lymphoma
06/07
09/23
Michail, Sonia
NCT02291523: The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis

Active, not recruiting
1
101
US
Fecal Microbial Transplant, FMT
Children's Hospital Los Angeles
Ulcerative Colitis
11/23
11/23
NCT03426826: The Gut-Brain Study

Active, not recruiting
1
10
US
FMT versus placebo, fecal microbial transplant vs placebo
Children's Hospital Los Angeles
Autism Spectrum Disorder (ASD), Gastro-Intestinal Disorder
03/26
06/26
CHLA-22-00049, NCT05218850: The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

Recruiting
1
10
US
Butyrate, Butyrate enemas
Children's Hospital Los Angeles
Ulcerative Colitis
06/27
06/27
PROBE, NCT00061828: A Prospective Database of Infants With Cholestasis

Recruiting
N/A
1000
Canada, US
Arbor Research Collaborative for Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Biliary Atresia, Neonatal Cholestasis
05/29
05/29
BASIC, NCT00345553: Biliary Atresia Study in Infants and Children

Recruiting
N/A
1265
Canada, US
Arbor Research Collaborative for Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Biliary Atresia
05/29
05/29
LOGIC, NCT00571272: Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis

Suspended
N/A
1675
Canada, US
Arbor Research Collaborative for Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Liver Diseases, Alagille Syndrome, Alpha 1-Antitrypsin Deficiency
05/29
05/29
MITOHEP, NCT01148550: Longitudinal Study of Mitochondrial Hepatopathies

Suspended
N/A
67
Canada, US
Arbor Research Collaborative for Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Michigan
Acute Liver Failure, Mitochondrial Diseases, End Stage Liver Disease, Respiratory Chain Deficiencies, Mitochondrial, Disorder of Fatty Acid Oxidation
05/29
05/29
NCT03325855: Fecal Microbiota Transplant National Registry

Recruiting
N/A
4000
Canada, US
None - Observational, Observational
American Gastroenterological Association, OpenBiome, University of California, San Diego, RX.Health Inc., University of Pennsylvania, University of Minnesota, Loyola University Chicago
Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome
08/27
08/27
Okawa, Erin
NCT04732416: HM15136 Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

Recruiting
2
16
Europe, US, RoW
HM15136
Hanmi Pharmaceutical Company Limited
Congenital Hyperinsulinism
03/25
03/25
NCT06363929: Continuous Glucose Monitoring in Neonatal Hyperinsulinism

Recruiting
N/A
15
US
Dexcom G6 continuous glucose monitor
MemorialCare Health System, DexCom, Inc.
Hyperinsulinism, Hypoglycemia Neonatal
06/25
12/25

Download Options